References
- Clark S. S., McLaughlin J., Timmons M., et al. Expression of a distinctive BCR-ABL oncogene in Ph-positive acute lym-phocytic leukemia (ALL). Science, 239: 775–777
- Hermans A., Gow J., Selleri L., et al. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 1988; 2: 628–633
- Kantarjian H. M., Talpaz M., Dhingra K., et al. Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411–2418
- Bloomfield C. D., Godlman A. I., Alimena G., et al. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 1986; 67: 415–420
- Fletcher J. A., Lynch E. A., Kimball V. M., Donnelly M., Tantravahi R., Sallan S. E. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77: 435–439
- Kantarjian H. M., Talpaz M., Dhingra K., et al. Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411–2418
- Dunlop L., Powles R., Singhal S., et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1996; 17: 365–369
- Grigg A. P. Approaches to the treatment of Philadelphia-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1993; 12: 431–435
- Arlin A. A., Feldman E. J., Ahmed T., Liebowitz D., Shapiro L. R., Wilmot P. L. Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph'-negative ALL. Acta Haematol. 1989; 81: 217–218
- Allen P., Morgan G. I., Weidemann L. M. Philadelphia chromosome-positive leukemia: the translocated genes and their gene products. Balliere's Clin. Haematol. 1992; 5: 897–929
- Verhoef G., Meeus P., Stul M., et al. Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes: report of two cases and review of literature. Cancer Genet. Cytogenet. 1992; 11: 233–248
- Secker-Walker L. M. The prognostic implications of chromosomal findings in acute lymphoblastic leukaemia. Cancer Genet. Cytogenet. 1984; 11: 233–248
- Raimondi S., Pui C. H., Head D. R., Rivera G. K., Behm F. G. Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia. Blood 1993; 82: 576–580
- Stass S., Mirro J., Melvin S., Pui C. H., Murphy S. B., Williams D. Lineage switch in acute leukemia. Blood 1984; 64: 701–706
- Pui C. H., Behm F. G., Raimondi S. C., et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N. Engl. J. Med. 1989; 321: 136–142
- Secker-Walker L. M., Craig J. M. Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review. Leukemia 1993; 7: 147–151
- Catovsky D. Ph-positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases. Br. J. Haematol 1979; 42: 493–498
- Gale R. P., Butturini A. Ph-chromosome positive acute leukemias and acute phase CML: one or two diseases? Two. Leukemia Res. 1990; 14: 295–297
- Guo J. Q., Hirsch-Ginsberg C. F., Xian Y. M., et al. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia. Hematol. Pathol 1993; 7: 91–106
- Melo J. V., Myint H., Galton D. A. G., Goldman J. M. p190 BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?. Leukemia 1994; 8: 208–211
- Tien H. F., Wang C. H., Chuang S. M., et al. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical and gene analysis. Leukemia 1992; 6: 907–914
- Voncken J. W., Kaartinen V., Pattengale P. K., Germeraad W. T. V., Groffen J., Heistercamp N. BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice. Blood 1995; 86: 4603–4611
- Skuse G. R., Ludlow J. W. Tumour suppressor genes in disease and therapy. Lancer 1995; 345: 902–906